help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandi, M. L.
Right arrow Articles by Marx, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandi, M. L.
Right arrow Articles by Marx, S. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 12 5658-5671
Copyright © 2001 by The Endocrine Society

Special Features

CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

Maria Luisa Brandi, Robert F. Gagel, Alberto Angeli, John P. Bilezikian, Paolo Beck-Peccoz, Cesare Bordi, Bernard Conte-Devolx, Alberto Falchetti, Riccardo Gionata Gheri, Alfonso Libroia, Cornelius J. M. Lips, Gaetano Lombardi, Massimo Mannelli, Furio Pacini, Bruce A. J. Ponder, Frank Raue, Britt Skogseid, Guido Tamburrano, Rajesh V. Thakker, Norman W. Thompson, Paola Tomassetti, Francesco Tonelli, Samuel A. Wells, Jr. and Stephen J. Marx

Department of Internal Medicine, University of Florence (M.L.B., A.F., M.M., F.T.), 50139 Florence, Italy; University of Texas, M. D. Anderson Cancer Center (R.F.G.), Houston, Texas 77030; Dipartimento di Scienze Cliniche e Biologiche, Medicina Interna I, University of Torino (A.A.), 10100 Torino, Italy; Department of Medicine, Columbia University College of Physicians and Surgeons (J.P.B.), New York, New York 10032; Institute of Endocrine Sciences, University of Milan, Ospedale Maggiore IRCCS (P.B.-P.), 20100 Milan, Italy; Department of Pathology and Laboratory Medicine, University of Parma (C.B.), 43100 Parma, Italy; Endocrinologie et Maladies Metaboliques, Timone Hospital (B.C.-D.), 13385 Marseilles, France; Unità di Endocrinologia, Azienda Ospedaliera Careggi (R.G.G.), Florence, Italy; Divisione di Endocrinologia, Ospedale Niguarda (A.L.), Milan, Italy; Department of Internal Medicine, University Medical Center (C.J.M.L.), 3508 GA Utrecht, The Netherlands; Department of Molecular and Clinical Endocrinology, Federico II University (G.L.), 80100 Naples, Italy; Department of Clinical Physiopathology, University of Florence (M.M., F.T.), Florence, Italy; Department of Endocrinology and Metabolism, Section of Endocrinology, University of Pisa (F.P.), 56100 Pisa, Italy; Department of Genetics, University of Cambridge (B.A.J.P.), Cambridge CB2 2XZ, United Kingdom; Endokrinologische Gemeinschaftspraxis (F.R.), 69111 Heidelberg, Germany; Endocrine Oncology Unit, University Hospital (B.S.), S-751 85 Uppsala, Sweden; Department of Clinical Science, Endocrine Section, University of Rome La Sapienza (G.T.), 00100 Rome, Italy; Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital (R.V.T.), Oxford OX3 9DU, United Kingdom; Division of Endocrine Surgery, University of Michigan Medical Center (N.W.T.), Ann Arbor, Michigan 48109-0331; Department of Internal Medicine and Gastroenterology, University of Bologna (P.T.), 40100 Bologna, Italy; Department of Surgery, Washington University School of Medicine (S.A.W.), St. Louis, Missouri 63110; and Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (S.J.M.), Bethesda, Maryland 20862

Address all correspondence and requests for reprints to: Maria Luisa Brandi, M.D., Ph.D., Department of Internal Medicine and Regional Center for Hereditary Endocrine Tumors, Viale G. Pieraccini 6, 50139 Florence, Italy. E-mail: m.brandi{at}dmi.unifi.it

Abstract

This is a consensus statement from an international group, mostly of clinical endocrinologists. MEN1 and MEN2 are hereditary cancer syndromes. The commonest tumors secrete PTH or gastrin in MEN1, and calcitonin or catecholamines in MEN2. Management strategies improved after the discoveries of their genes. MEN1 has no clear syndromic variants. Tumor monitoring in MEN1 carriers includes biochemical tests yearly and imaging tests less often. Neck surgery includes subtotal or total parathyroidectomy, parathyroid cryopreservation, and thymectomy. Proton pump inhibitors or somatostatin analogs are the main management for oversecretion of entero-pancreatic hormones, except insulin. The roles for surgery of most entero-pancreatic tumors present several controversies: exclusion of most operations on gastrinomas and indications for surgery on other tumors. Each MEN1 family probably has an inactivating MEN1 germline mutation. Testing for a germline MEN1 mutation gives useful information, but rarely mandates an intervention. The most distinctive MEN2 variants are MEN2A, MEN2B, and familial medullary thyroid cancer (MTC). They vary in aggressiveness of MTC and spectrum of disturbed organs. Mortality in MEN2 is greater from MTC than from pheochromocytoma. Thyroidectomy, during childhood if possible, is the goal in all MEN2 carriers to prevent or cure MTC. Each MEN2 index case probably has an activating germline RET mutation. RET testing has replaced calcitonin testing to diagnose the MEN2 carrier state. The specific RET codon mutation correlates with the MEN2 syndromic variant, the age of onset of MTC, and the aggressiveness of MTC; consequently, that mutation should guide major management decisions, such as whether and when to perform thyroidectomy.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
G. H Sakorafas, H. Friess, and G. Peros
The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy
Endocr. Relat. Cancer, December 1, 2008; 15(4): 871 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
I. N Milos, K. Frank-Raue, N. Wohllk, A. L. Maia, E. Pusiol, A. Patocs, M. Robledo, J. Biarnes, M. Barontini, T. P Links, et al.
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation
Endocr. Relat. Cancer, December 1, 2008; 15(4): 1035 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Kovac, K. Smith, G. J. Anderson, J. R. Burgess, A. Shulkes, and G. S. Baldwin
Interrelationships between circulating gastrin and iron status in mice and humans
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G855 - G861.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
D M Lourenco Jr, R A Toledo, I I Mackowiak, F L Coutinho, M G Cavalcanti, J E M Correia-Deur, F Montenegro, S A C Siqueira, L C Margarido, M C Machado, et al.
Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile
Eur. J. Endocrinol., September 1, 2008; 159(3): 259 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Colombo-Benkmann, Z. Li, B. Riemann, K. Hengst, H. Herbst, R. Keuser, U. Gross, S. Rondot, F. Raue, N. Senninger, et al.
Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma.
Eur. J. Endocrinol., June 1, 2008; 158(6): 811 - 816.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. S. Sippel, M. Kunnimalaiyaan, and H. Chen
Current Management of Medullary Thyroid Cancer
Oncologist, May 1, 2008; 13(5): 539 - 547.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Hong, L. Ye, R. Gagel, L. Chintala, A. K. El Naggar, J. Wright, and R. Kurzrock
Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib
Mol. Cancer Ther., May 1, 2008; 7(5): 1001 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. B. Lodish, A. C. Powell, M. Abu-Asab, C. Cochran, P. Lenz, S. K. Libutti, J. F. Pingpank, M. Tsokos, and P. Gorden
Insulinoma and Gastrinoma Syndromes from a Single Intrapancreatic Neuroendocrine Tumor
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1123 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
L Foppiani, F Forzano, I Ceccherini, W Bruno, P Ghiorzo, F Caroli, P Quilici, R Bandelloni, A Arlandini, G Sartini, et al.
Uncommon association of germline mutations of RET proto-oncogene and CDKN2A gene
Eur. J. Endocrinol., March 1, 2008; 158(3): 417 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Z. Yin, L. Williams-Simons, A. F. Parlow, S. Asa, and L. S. Kirschner
Pituitary-Specific Knockout of the Carney Complex Gene Prkar1a Leads to Pituitary Tumorigenesis
Mol. Endocrinol., February 1, 2008; 22(2): 380 - 387.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. J. Wray, T. A. Rich, S. G. Waguespack, J. E. Lee, N. D. Perrier, and D. B. Evans
Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?
Ann. Surg. Oncol., January 1, 2008; 15(1): 293 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Korsisaari, J. Ross, X. Wu, M. Kowanetz, N. Pal, L. Hall, J. Eastham-Anderson, W. F. Forrest, N. Van Bruggen, F. V. Peale, et al.
Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1
Clin. Cancer Res., January 1, 2008; 14(1): 249 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Karagiannis, D. P Mikhailidis, V. G Athyros, and F. Harsoulis
Pheochromocytoma: an update on genetics and management
Endocr. Relat. Cancer, December 1, 2007; 14(4): 935 - 956.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
X.-H. Jiang, J.-L. Lu, B. Cui, Y.-J. Zhao, W.-q. Wang, J.-M. Liu, W.-Q. Fang, Y.-N. Cao, Y. Ge, C.-x. Zhang, et al.
MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1
Endocr. Relat. Cancer, December 1, 2007; 14(4): 1073 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. Beckers and A. F Daly
The clinical, pathological, and genetic features of familial isolated pituitary adenomas
Eur. J. Endocrinol., October 1, 2007; 157(4): 371 - 382.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Tham, U. Grandell, E. Lindgren, G. Toss, B. Skogseid, and M. Nordenskjold
Clinical Testing for Mutations in the MEN1 Gene in Sweden: A Report on 200 Unrelated Cases
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3389 - 3395.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
C. M. Intenzo, S. Jabbour, H. C. Lin, J. L. Miller, S. M. Kim, D. M. Capuzzi, and E. P. Mitchell
Scintigraphic Imaging of Body Neuroendocrine Tumors
RadioGraphics, September 1, 2007; 27(5): 1355 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Georgitsi, A. Raitila, A. Karhu, R. B. van der Luijt, C. M. Aalfs, T. Sane, O. Vierimaa, M. J. Makinen, K. Tuppurainen, R. Paschke, et al.
Germline CDKN1B/p27Kip1 Mutation in Multiple Endocrine Neoplasia
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3321 - 3325.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
D M Pritchard
Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1
Gut, May 1, 2007; 56(5): 606 - 607.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Ozawa, S. K. Agarwal, C. M. Mateo, A. L. Burns, T. S. Rice, P. A. Kennedy, C. M. Quigley, W. F. Simonds, L. S. Weinstein, S. C. Chandrasekharappa, et al.
The Parathyroid/Pituitary Variant of Multiple Endocrine Neoplasia Type 1 Usually Has Causes Other than p27Kip1 Mutations
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1948 - 1951.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
O. Chabre, C. Piolat, J.-F. Dyon, A. Machens, J. Hoegel, and H. Dralle
Childhood Progression of Hereditary Medullary Thyroid Cancer
N. Engl. J. Med., April 12, 2007; 356(15): 1583 - 1585.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Georgitsi, A. Raitila, A. Karhu, K. Tuppurainen, M. J. Makinen, O. Vierimaa, R. Paschke, W. Saeger, R. B. van der Luijt, T. Sane, et al.
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations
PNAS, March 6, 2007; 104(10): 4101 - 4105.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. Raue and K. Frank-Raue
Primary hyperparathyroidism--what the nephrologist should know--an update
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 696 - 699.
[Full Text] [PDF]

Home page
 Arch SurgHome page
R. Asari, C. Scheuba, K. Kaczirek, and B. Niederle
Estimated Risk of Pheochromocytoma Recurrence After Adrenal-Sparing Surgery in Patients With Multiple Endocrine Neoplasia Type 2A
Arch Surg, December 1, 2006; 141(12): 1199 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. M. Henrich, A. D. Rogol, P. D'Amour, M. A. Levine, J. B. Hanks, and D. E. Bruns
Persistent Hypercalcemia After Parathyroidectomy in an Adolescent and Effect of Treatment With Cinacalcet HCl
Clin. Chem., December 1, 2006; 52(12): 2286 - 2293.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
A. Fukuuchi, Y. Nagamura, H. Yaguchi, N. Ohkura, T. Obara, and T. Tsukada
A Whole MEN1 Gene Deletion Flanked by Alu Repeats in a Family with Multiple Endocrine Neoplasia Type 1
Jpn. J. Clin. Oncol., November 1, 2006; 36(11): 739 - 744.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K Frank-Raue, H Buhr, H Dralle, E Klar, N Senninger, T Weber, S Rondot, W Hoppner, and F Raue
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype.
Eur. J. Endocrinol., August 1, 2006; 155(2): 229 - 236.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. J. Marx and W. F. Simonds
Imaging to detect early endocrine cancers.
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2861 - 2863.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
Endocr. Rev., August 1, 2006; 27(5): 535 - 560.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Jimenez, G. Cote, A. Arnold, and R. F. Gagel
Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes?
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2851 - 2858.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
O. Iliopoulos, G. Chan-Smutko, R. G. Gonzalez, D. N. Louis, and J. R. Stone
Case records of the Massachusetts General Hospital. Case 23-2006. A 36-year-old man with numbness in the right hand and hypertension.
N. Engl. J. Med., July 27, 2006; 355(4): 394 - 402.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Iervolino, R. Iuliano, F. Trapasso, G. Viglietto, R. M. Melillo, F. Carlomagno, M. Santoro, and A. Fusco
The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins.
Cancer Res., June 15, 2006; 66(12): 6280 - 6287.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
M Niedziela
Pathogenesis, diagnosis and management of thyroid nodules in children.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 427 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Katai, A. Sakurai, S. Uchino, K. Minemura, K. Hashizume, and Y. Fukushima
Novel 14 Base-Pair Deletion of the MEN1 Gene in a Patient with Recurrent Primary Hyperparathyroidism
Jpn. J. Clin. Oncol., June 1, 2006; 36(6): 395 - 397.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. M.A. Dreijerink, K. W. Mulder, G. S. Winkler, J. W.M. Hoppener, C. J.M. Lips, and H.Th. M. Timmers
Menin Links Estrogen Receptor Activation to Histone H3K4 Trimethylation.
Cancer Res., May 1, 2006; 66(9): 4929 - 4935.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
J. V. Schaffer, H. Kamino, A. Witkiewicz, J. M. McNiff, and S. J. Orlow
Mucocutaneous Neuromas: An Underrecognized Manifestation of PTEN Hamartoma-Tumor Syndrome.
Arch Dermatol, May 1, 2006; 142(5): 625 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
J. G. H. Hubbard, F. Sebag, S. Maweja, and J.-F. Henry
Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Arch Surg, March 1, 2006; 141(3): 235 - 239.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
A. F. Scarsbrook, R. V. Thakker, J. A. H. Wass, F. V. Gleeson, and R. R. Phillips
Multiple Endocrine Neoplasia: Spectrum of Radiologic Appearances and Discussion of a Multitechnique Imaging Approach.
RadioGraphics, March 1, 2006; 26(2): 433 - 451.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C.-H. Lee, L.-M. Tseng, J.-Y. Chen, H.-Y. Hsiao, and A.-H. Yang
Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1: Individualized Management With Low Recurrence Rates
Ann. Surg. Oncol., January 1, 2006; 13(1): 103 - 109.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. S. Kirschner
Emerging Treatment Strategies for Adrenocortical Carcinoma: A New Hope
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 14 - 21.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. M A Dreijerink, A. P van Beek, E. G W M Lentjes, J. G Post, R. B van der Luijt, M. R C.-v. Dijk, and C. J M Lips
Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease
Eur. J. Endocrinol., December 1, 2005; 153(6): 741 - 746.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. S. Nadella and L. S. Kirschner
Disruption of Protein Kinase A Regulation Causes Immortalization and Dysregulation of D-Type Cyclins
Cancer Res., November 15, 2005; 65(22): 10307 - 10315.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
R. D. Read, P. J. Goodfellow, E. R. Mardis, N. Novak, J. R. Armstrong, and R. L. Cagan
A Drosophila Model of Multiple Endocrine Neoplasia Type 2
Genetics, November 1, 2005; 171(3): 1057 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
F. D. Moore and R. G. Dluhy
Prophylactic Thyroidectomy in MEN-2A -- A Stitch in Time?
N. Engl. J. Med., September 15, 2005; 353(11): 1162 - 1164.
[Full Text] [PDF]

Home page
 PediatricsHome page
M. B. Jackson, M. Guttenberg, H. Hedrick, and T. Moshang Jr
Multiple Endocrine Neoplasia Type 2A in a Kindred With C634Y Mutation
Pediatrics, September 1, 2005; 116(3): e468 - e471.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. J. Marx and W. F. Simonds
Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes
Endocr. Rev., August 1, 2005; 26(5): 615 - 661.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
K J Bradley, B M Cavaco, M R Bowl, B Harding, A Young, and R V Thakker
Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism
J. Med. Genet., August 1, 2005; 42(8): e51 - e51.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. S. Lora, S. G. Waguespack, J. F. Moley, and E. C. Walvoord
Adrenal Ganglioneuromas in Children with Multiple Endocrine Neoplasia Type 2: A Report of Two Cases
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4383 - 4387.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Frank-Raue, S. Rondot, W. Hoeppner, P. Goretzki, F. Raue, and W. Meng
Coincidence of Multiple Endocrine Neoplasia Types 1 and 2: Mutations in the RET Protooncogene and MEN1 Tumor Suppressor Gene in a Family Presenting with Recurrent Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4063 - 4067.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Machens, M. Brauckhoff, H.-J. Holzhausen, P. N. Thanh, H. Lehnert, and H. Dralle
Codon-Specific Development of Pheochromocytoma in Multiple Endocrine Neoplasia Type 2
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3999 - 4003.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
T. Snabboon, W. Plengpanich, S. Siriwong, N. Wisedopas, S. Suwanwalaikorn, W. Khovidhunkit, and V. Shotelersuk
A Novel Germline Mutation, 1793delG, of the MEN1 Gene Underlying Multiple Endocrine Neoplasia Type 1
Jpn. J. Clin. Oncol., May 1, 2005; 35(5): 280 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
L. A. Lambert, S. E. Shapiro, J. E. Lee, N. D. Perrier, M. Truong, M. J. Wallace, A. O. Hoff, R. F. Gagel, and D. B. Evans
Surgical Treatment of Hyperparathyroidism in Patients With Multiple Endocrine Neoplasia Type 1
Arch Surg, April 1, 2005; 140(4): 374 - 382.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. E. Garber and K. Offit
Hereditary Cancer Predisposition Syndromes
J. Clin. Oncol., January 10, 2005; 23(2): 276 - 292.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Benito, S. L. Asa, V. A. LiVolsi, V. A. West, and P. J. Snyder
Gonadotroph Tumor Associated with Multiple Endocrine Neoplasia Type 1
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 570 - 574.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
J W Cardinal, L Bergman, N Hayward, A Sweet, J Warner, L Marks, D Learoyd, T Dwight, B Robinson, M Epstein, et al.
A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing
J. Med. Genet., January 1, 2005; 42(1): 69 - 74.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Santoro, R. M. Melillo, F. Carlomagno, G. Vecchio, and A. Fusco
Minireview: RET: Normal and Abnormal Functions
Endocrinology, December 1, 2004; 145(12): 5448 - 5451.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Asgharian, M. L. Turner, F. Gibril, L. K. Entsuah, J. Serrano, and R. T. Jensen
Cutaneous Tumors in Patients with Multiple Endocrine Neoplasm Type 1 (MEN1) and Gastrinomas: Prospective Study of Frequency and Development of Criteria with High Sensitivity and Specificity for MEN1
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5328 - 5336.
[Abstract] [Full Text] [PDF]